<<

Annex II (ad section 1 subsection 1) (marketable but non-prescribable narcotic )

(The original text has been published in the Federal Law Gazette (Bundesgesetzblatt - BGBl.) I 2001, 1187 - 1189)

Column 1 contains the International Nonproprietary Names (INN) of the World Health Organisation. In naming a substance, the INN has priority over all other names. Column 2 contains other non-protected names of substances (short or trivial names). If there is no INN for a substance, the name printed in bold in this column may be used to name the substance unambiguously. All other names not printed in bold are not unambiguous in scientific terms. For this reason, they have to be used together with the name in column 3. Column 3 contains the chemical names of substances pursuant to the nomenclature of the International Union of Pure and Applied Chemistry (IUPAC). If no name is listed in column 1 or 2, the name listed in column 3 is to be used.

INN other non-protected or trivial names chemical names (IUPAC) Amphetaminil - (Phenyl)[ (1-phenylpropan-2-yl) amino] acetonitril - (BZP) 1-Benzylpiperazin - Butobarbital 5-Butyl-5-ethylpyrimidin-2, 4, 6 (1H,3H, 5H)-trion - meta-Chlorphenylpiperazine (m-CPP) 1- (3-Chlorphenyl)piperazin - 7-(10,11-Dihydro-5H-dibenzo(a,d)(7)annulen-5- ylamino)heptansäure - 5-Phenyl-4, 5-dihydro-1, 3-oxazol-2-ylazan Butalbital - 5-Allyl-5-isobutylbarbitursäure - CP 47,497 5-(1,1-Dimethylheptyl)-2-[ (1RS,3SR)-3- (cis-3-[ 4- (1, 1-Dimethyl-heptyl) -2-hydroxyphenyl] -cyclohexanol) hydroxycyclohexyl] –phenol - CP 47,497-C6-Homolog 5-(1,1-Dimethylhexyl)-2-[ (1RS,3SR)-3- (cis-3-[ 4- (1, 1-Dimethyl-hexyl) -2-hydroxyphenyl] -cyclohexanol) hydroxycyclohexyl] -phenol - CP 47,497-C8-Homolog 5-(1,1-Dimethyloctyl)-2-[ (1RS,3SR)-3- (cis-3-[ 4- (1, 1-Dimethyl-octyl) -2-hydroxyphenyl] -cyclohexanol) hydroxycyclohexyl] -phenol - CP 47,497-C9-Homolog 5-(1,1-Dimethylnonyl)-2-[ (1RS,3SR)- (cis-3-[ 4- (1, 1-Dimethyl-nonyl) -2-hydroxyphenyl] -cyclohexanol) 3-hydroxycyclohexyl] -phenol Cetobemidone 1- (4- (3-Hydroxyphenyl) -1-methyl-4- piperidyl) propan-1-on - d- Methyl(3ß-(benzoyloxy)tropan- 2alpha-carboxylat - Dextromethadone (S)-6-Dimethylamino-4,4- diphenylheptan-3-on Cyclobarbital - 5-(Cyclohex-1-en-1-yl) -5-ethylpyrimidin-2, 4, 6 (1H, 3H, 5H) –trion - (S)-3-Methyl-4-morpholino-2,2- diphenyl-1-(pyrrolidin-1-yl)butan-1- on - ((2S, 3R) -4-Dimethylamino-3-methyl-1, 2-diphenylbutan-2-yl)propionat - Diamorphine [ (5R,6S)-4,5-Epoxy-17- methylmorphin-7-en-3, 6-diyl] diacetat – if intended for the production of preparations for medical purposes Difenoxin - 1-(3-Cyan-3,3-diphenylpropyl)- 4 - phenylpiperidin-4-carbonsäure except in preparations which, without another substance from annexes I to III, contain up to 0.5 mg of Difenoxin, calculated as a base, per portion and, in relation to this quantity, at least 5 per cent of atropine sulphate -- - 4, 5alpha-Epoxy-17-methyl--3, 6alpha- diol - Dihydrothebaine 4,5alpha-Epoxy-3,6-dimethoxy-17- methylmorphin-6-en - Ethyl(1-(3-cyan-3,3-diphenyl-propyl)-4- phenylpiperidin-4-carboxylat) - except in preparations which, without another substance from annexes I to III, contain up to 0.25 per cent of Diphenoxylate, calculated as a base, or up to 2.5 mg per portion and, in relation to these quantities, at least 1 per cent of atropine sulphate - - Ecgonine 3ß-Hydroxytropan-2ß-carbonsäure - Erythroxylum (plants and parts of plants belonging to the erythroxylum coca - species - including the bolivianum, spruceanum and novogranatense varieties) Ethchlorvynol - 1-Chlor-3-ethylpent-1-en-4-in-3-ol Ethinamate - (1-Ethinylcyclohexyl)carbamat 3-O- (Ethylmorphine) 4,5alpha-Epoxy-3-ethoxy-17-methylmorphin-7- en-6alpha-ol except in preparations which, without another substance from annexes I to III, contain up to 2.5 per cent of Ethylmorphine or up to 100 mg per portion, calculated as a base- Etilamfetamin N-Ethylamphetamine (Ethyl) (1-phenylpropan-2-yl)azan Fencamfamine - N-Ethyl-3-phenylbicyclo[ 2.2.1]heptan-2-amin Glutethimide - 3-Ethyl-3-phenylpiperidin-2, 6-dion - Isocodeine 4,5alpha-Epoxy-3-methoxy-17-methylmorphin-7- en-6ß-ol - 6-Dimethylamino-5-methyl-4, 4-diphenylhexan-3 –on - JWH-018 (Naphthalin-1-yl) (1-pentyl-1H-indol-3-yl)methanon (1-Pentyl-3-(1-naphthoyl)indol) - JWH-019 (Naphthalin-1-yl) (1-hexyl-1H- indol-3-yl)methanon (1-Hexyl-3- (1-naphthoyl)indol) - JWH-073 (Naphthalin-1-yl) (1-butyl-1H-indol-3-yl)methanon (1-Butyl-3- (1-naphthoyl) indol) Levamfetamin Levamphetamine (R) -1-Phenylpropan-2-ylazan - Levmetamfetamine (R)-(Methyl) (1-phenylpropan-2-yl)azan (Levometamfetamine) Levomoramide - (R)-3-Methyl-4-morpholino-2,2-diphenyl-1- (pyrrolidin-1-yl)butan-1-on - (9R,13R,14R)-17-Methylmorphinan-3-ol 17-methylmorphinan-3-ol - 5-(4-Chlorphenyl)-2,5-dihydro-3H-imidazol[2,1-a] isoindol-5-ol - 3-Chlor-N-(1-phenylpropan-2-yl)propan-1-amin - (2-Methyl-2-propylpropan-1, 3-diyl)dicarbamat - (Phenylcarbamoyl) (3-(1-phenylpropan-2-yl) -1,2,3- oxadiazol-3-ium-5-yl) azanid Metamfetamin (2S) -N-Methyl-1-phenylpropan-2-amin Methaqualon - 2-Methyl-3- (2-methylphenyl)chinazolin-4 (3H) –on Methyprylon - 3, 3-Diethyl-5-methylpiperidin-2, 4-dion - 4, 5alpha-Epoxy-6-methoxy-17-methylmorphina-6, 8-dien-3-ol (RS) -Metamfetamin Methamphetamine racemate (RS)-(Methyl)(1-phenylpropan-2-yl)azan - intermediate 4-Dimethylamino-2, 2-diphenylpentannitril (Premethadone)

(RS;SR)-Methylphenidat - Methyl((RS;SR) (phenyl) (2-piperidyl) acetat) - Concentrate of poppy straw (the material arising when plants and parts of plants - of the species are subjected to a process for the concentration of the alkaloids) - Moramide intermediate 3-Methyl-4-morpholino-2, 2-diphenylbutansäure (Premoramide)

Nicocodine 6-Nicotinoylcodeine (4, 5alpha-Epoxy-3-methoxy-17-methylmorphin-7- en- 6alpha-yl) nicotinat Nicodicodin 6-Nicotinoyldihydrocodeine (4,5alpha-Epoxy-3-methoxy-17- methylmorphinan-6alpha-yl)nicotinat - Papaver bracteatum - (plants and parts of plants,except seeds, belonging to the Papaver bracteatum species) - except for decorative purposes - - - intermediate A 1-Methyl-4-phenylpiperidin-4-carbonitril (Prepethidin) - Pethidine intermediate B Ethyl(4-phenylpiperidin-4-carboxylat) () - Pethidine intermediate C 1-Methyl-4-phenylpiperidin-4-carbonsäure () - 14-Hydroxydihydromorphinon 4, 5a-Epoxy-3, 14- dihydroxy-17-methylmorphinan- 6-on - (2S,3S) -3,4-Dimethyl-2-phenylmorpholin - 3 -Methyl-2-phenylmorpholin Morpholinylethylmorphine 4, 5alpha-Epoxy-17-methyl-3-(2- morpholinoethoxy)morphin-7- en- 6alpha-ol - except in preparations which, without another substance from annexes I to III, contain, as solutions, up to 0.15 per cent of pholcodine, but not more than 150 mg per package unit or up to 20 mg per dosage unit, calculated as a base - - N- (1-Piperidinopropan-2-yl)-N- (2- pyridyl)propanamid - 2- (Pyrrolidin-1-yl) -1- (p-tolyl)pentan-1-on Racemoramide - (RS)-3-Methyl-4-morpholino-2,2-diphenyl-1- (pyrrolidin-1-yl)butan-1-on - (9RS,13RS,14RS)-17-Methyl-morphinan-3-ol - delta9-Tetrahydro-cannabinol 6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro- (delta9-THC) 6H-benzo(c)chromen-1-ol - Tetrahydrothebaine 4,5alpha-Epoxy-3, 6-dimethoxy-17 - methylmorphinan Secbutabarbital Butabarbital 5- (Butan-2-yl)-5-ethylpyrimidin-2,4,6 (1H, 3H, 5H) –trion Acetyldihydrocodeinone (4, 5alpha-Epoxy-3-methoxy-17-methylmorphin- 6- en-6-yl) acetat - 4,5alpha-Epoxy-3,6-dimethoxy-1 7-methylmorphina- 6,8-dien cis-Tilidin - Ethyl((1RS,2RS)-2-dimethyl-amino-1- phenylcyclohex-3-encarboxylat) Vinylbital - 5-Ethenyl-5- (pentan-2-yl)pyrimidin-2, 4, 6 (1H, 3H, 5H) – trion Zipeprol - 1-Methoxy-3-(4-(2-methoxy-2- phenylethyl)piperazin-1-yl) - 1-phenylpropan-2 –ol

- the esters, ethers and molecular compounds of the substances listed in this annex, as well as the esters and ethers of the substances listed in annex III, with the exception of gamma-hydroxybutyric acid (GHB), if they do not appear in another annex and whenever the existence of such esters, ethers and molecular compounds is possible;

- the salts of the substances listed in this annex, whenever the existence of such salts is possible, as well as the salts and molecular compounds of the substances listed in annex III, whenever the existence of such salts and molecular compounds is possible and they are not used for medical, dental or veterinary purposes;

- the preparations of the substances listed in this annex unless a) they are exclusively intended for diagnostic or analytical purposes, without being used on or in the human or animal body, and their content of one or more narcotics, in the case of lyophilizates and mixtures of substances intended for similar use in ready-made solutions, does not exceed 0.01 per cent in each case or the substances in the preparations are isotope-modified or b)they are specifically exempted.